{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "MERS", "SARS", "antiviral", "medicinal plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36362351", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "05"}], "Language": ["eng"], "ELocationID": ["13564", "10.3390/ijms232113564"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "21", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "05"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update.", "Abstract": {"AbstractText": ["Several human diseases are caused by viruses, including cancer, Type I diabetes, Alzheimer's disease, and hepatocellular carcinoma. In the past, people have suffered greatly from viral diseases such as polio, mumps, measles, dengue fever, SARS, MERS, AIDS, chikungunya fever, encephalitis, and influenza. Recently, COVID-19 has become a pandemic in most parts of the world. Although vaccines are available to fight the infection, their safety and clinical trial data are still questionable. Social distancing, isolation, the use of sanitizer, and personal productive strategies have been implemented to prevent the spread of the virus. Moreover, the search for a potential therapeutic molecule is ongoing. Based on experiences with outbreaks of SARS and MERS, many research studies reveal the potential of medicinal herbs/plants or chemical compounds extracted from them to counteract the effects of these viral diseases. COVID-19's current status includes a decrease in infection rates as a result of large-scale vaccination program implementation by several countries. But it is still very close and needs to boost people's natural immunity in a cost-effective way through phytomedicines because many underdeveloped countries do not have their own vaccination facilities. In this article, phytomedicines as plant parts or plant-derived metabolites that can affect the entry of a virus or its infectiousness inside hosts are described. Finally, it is concluded that the therapeutic potential of medicinal plants must be analyzed and evaluated entirely in the control of COVID-19 in cases of uncontrollable SARS infection."]}, "AuthorList": [{"Identifier": ["0000-0001-5525-708X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Informatics, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi Arabia."}], "LastName": "Jamal", "ForeName": "Qazi Mohammad Sajid", "Initials": "QMS"}], "GrantList": [{"GrantID": "Project number: QU-IF-2-2-2-26338", "Agency": "The Deputyship for Research &amp; Innovation, Ministry of Education and Qassim University, Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["epidemiology"], "DescriptorName": "COVID-19"}, {"QualifierName": ["pharmacology", "therapeutic use", "chemistry"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Disease Outbreaks"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Virus Diseases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The author declares no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sarid R., Gao S.-J. Viruses and human cancer: From detection to causality. Cancer Lett. 2011;305:218\u2013227. doi: 10.1016/j.canlet.2010.09.011.", "ArticleIdList": ["10.1016/j.canlet.2010.09.011", "PMC3037427", "20971551"]}, {"Citation": "Isaacs S.R., Foskett D.B., Maxwell A.J., Ward E.J., Faulkner C.L., Luo J.Y., Rawlinson W.D., Craig M.E., Kim K.W. Viruses and type 1 diabetes: From enteroviruses to the virome. Microorganisms. 2021;9:1519. doi: 10.3390/microorganisms9071519.", "ArticleIdList": ["10.3390/microorganisms9071519", "PMC8306446", "34361954"]}, {"Citation": "Readhead B., Haure-Mirande J.-V., Funk C.C., Richards M.A., Shannon P., Haroutunian V., Sano M., Liang W.S., Beckmann N.D., Price N.D., et al. Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 2018;99:64\u201382.e7. doi: 10.1016/j.neuron.2018.05.023.", "ArticleIdList": ["10.1016/j.neuron.2018.05.023", "PMC6551233", "29937276"]}, {"Citation": "Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. Full-genome evolutionary analysis of the novel Corona virus (2019-ncov) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol. 2020;79:104212. doi: 10.1016/j.meegid.2020.104212.", "ArticleIdList": ["10.1016/j.meegid.2020.104212", "PMC7106301", "32004758"]}, {"Citation": "Pal M., Berhanu G., Desalegn C., Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020;12:e7423. doi: 10.7759/cureus.7423.", "ArticleIdList": ["10.7759/cureus.7423", "PMC7182166", "32337143"]}, {"Citation": "WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 21 September 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Christou L. The global burden of bacterial and viral zoonotic infections. Clin. Microbiol. Infect. 2011;17:326\u2013330. doi: 10.1111/j.1469-0691.2010.03441.x.", "ArticleIdList": ["10.1111/j.1469-0691.2010.03441.x", "PMC7129620", "21129102"]}, {"Citation": "Sharma R. Viral diseases and antiviral activity of some medicinal plants with special reference to ajmer. J. Antivir. Antiretrovir. 2019;11:185. doi: 10.35248/1948-5964.19.11.186.", "ArticleIdList": ["10.35248/1948-5964.19.11.186"]}, {"Citation": "Guzzi P.H., Mercatelli D., Ceraolo C., Giorgi F.M. Master regulator analysis of the SARS-CoV-2/human Interactome. J. Clin. Med. 2020;9:982. doi: 10.3390/jcm9040982.", "ArticleIdList": ["10.3390/jcm9040982", "PMC7230814", "32244779"]}, {"Citation": "Guerriero G., Berni R., Mu\u00f1oz-Sanchez J., Apone F., Abdel-Salam E., Qahtan A., Alatar A., Cantini C., Cai G., Hausman J.-F., et al. Production of plant secondary metabolites: Examples, tips and suggestions for Biotechnologists. Genes. 2018;9:309. doi: 10.3390/genes9060309.", "ArticleIdList": ["10.3390/genes9060309", "PMC6027220", "29925808"]}, {"Citation": "Remali J., Aizat W.M. A review on plant bioactive compounds and their modes of action against coronavirus infection. Front. Pharmacol. 2021;11:589044. doi: 10.3389/fphar.2020.589044.", "ArticleIdList": ["10.3389/fphar.2020.589044", "PMC7845143", "33519449"]}, {"Citation": "Dudani T., Saraogi A. Use of herbal medicines on coronavirus. Acta Sci. Pharm. Sci. 2020;4:61\u201363. doi: 10.31080/ASPS.2020.04.0518.", "ArticleIdList": ["10.31080/ASPS.2020.04.0518"]}, {"Citation": "Khanna K., Kohli S.K., Kaur R., Bhardwaj A., Bhardwaj V., Ohri P., Sharma A., Ahmad A., Bhardwaj R., Ahmad P. Herbal Immune-boosters: Substantial warriors of pandemic COVID-19 battle. Phytomedicine. 2021;85:153361. doi: 10.1016/j.phymed.2020.153361.", "ArticleIdList": ["10.1016/j.phymed.2020.153361", "PMC7532351", "33485605"]}, {"Citation": "Ling C.-Q. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) J. Integr. Med. 2020;18:87\u201388. doi: 10.1016/j.joim.2020.02.004.", "ArticleIdList": ["10.1016/j.joim.2020.02.004", "PMC7129043", "32122812"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., Ganesan S., Venugopal A., Venkatesan D., Ganesan H., et al. COVID-19: A promising cure for the global panic. Sci. Total Environ. 2020;725:138277. doi: 10.1016/j.scitotenv.2020.138277.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "Prasad K., Kumar V. Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2. Curr. Res. Pharmacol. Drug Discov. 2021;2:100042. doi: 10.1016/j.crphar.2021.100042.", "ArticleIdList": ["10.1016/j.crphar.2021.100042", "PMC8317454", "34870150"]}, {"Citation": "Lv H., Shi L., Berkenpas J.W., Dao F.-Y., Zulfiqar H., Ding H., Zhang Y., Yang L., Cao R. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design. Brief. Bioinform. 2021;22:bbab320. doi: 10.1093/bib/bbab320.", "ArticleIdList": ["10.1093/bib/bbab320", "PMC8511807", "34410360"]}, {"Citation": "Elkaeed E.B., Youssef F.S., Eissa I.H., Elkady H., Alsfouk A.A., Ashour M.L., El Hassab M.A., Abou-Seri S.M., Metwaly A.M. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease. Int. J. Mol. Sci. 2022;23:6912. doi: 10.3390/ijms23136912.", "ArticleIdList": ["10.3390/ijms23136912", "PMC9266348", "35805916"]}, {"Citation": "Human Coronavirus Types.  [(accessed on 22 September 2022)]; Available online:  https://www.cdc.gov/coronavirus/types.html."}, {"Citation": "Chan J.F.-W., Kok K.-H., Zhu Z., Chu H., To K.K.-W., Yuan S., Yuen K.-Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9:221\u2013236. doi: 10.1080/22221751.2020.1719902.", "ArticleIdList": ["10.1080/22221751.2020.1719902", "PMC7067204", "31987001"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20131448. doi: 10.1126/science.abb2762.", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Rossi G.A., Sacco O., Mancino E., Cristiani L., Midulla F. Differences and similarities between SARS-COV and SARS-CoV-2: Spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Infection. 2020;48:665\u2013669. doi: 10.1007/s15010-020-01486-5.", "ArticleIdList": ["10.1007/s15010-020-01486-5", "PMC7393809", "32737833"]}, {"Citation": "Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N.G., Decroly E. The spike glycoprotein of the new coronavirus 2019-ncov contains a furin-like cleavage site absent in cov of the same clade. Antivir. Res. 2020;176:104742. doi: 10.1016/j.antiviral.2020.104742.", "ArticleIdList": ["10.1016/j.antiviral.2020.104742", "PMC7114094", "32057769"]}, {"Citation": "Rabaan A.A., Al-Ahmed S.H., Haque S., Sah R., Tiwari R., Malik Y.S., Dhama K., Yatoo M.I., Bonilla-Aldana D.K., Rodriguez-Morales A.J. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez. Med. 2020;28:174\u2013184.", "ArticleIdList": ["32275259"]}, {"Citation": "Yuan Y., Cao D., Zhang Y., Ma J., Qi J., Wang Q., Lu G., Wu Y., Yan J., Shi Y., et al. Cryo-EM structures of MERS-COV and SARS-COV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 2017;8:15092. doi: 10.1038/ncomms15092.", "ArticleIdList": ["10.1038/ncomms15092", "PMC5394239", "28393837"]}, {"Citation": "Williamson G., Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (COVID-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem. Pharmacol. 2020;178:114123. doi: 10.1016/j.bcp.2020.114123.", "ArticleIdList": ["10.1016/j.bcp.2020.114123", "PMC7316054", "32593613"]}, {"Citation": "Maj M., Fake G.M., Walker J.H., Saltzman R., Howard J.A. Oral Administration of Coronavirus Spike Protein Provides Protection to Newborn Pigs When Challenged with PEDV. Vaccines. 2021;9:1416. doi: 10.3390/vaccines9121416.", "ArticleIdList": ["10.3390/vaccines9121416", "PMC8706244", "34960163"]}, {"Citation": "Schoeman D., Fielding B.C. Coronavirus envelope protein: Current knowledge. Virol. J. 2019;16:69. doi: 10.1186/s12985-019-1182-0.", "ArticleIdList": ["10.1186/s12985-019-1182-0", "PMC6537279", "31133031"]}, {"Citation": "Jimenez-Guarde\u00f1o J.M., Nieto-Torres J.L., DeDiego M.L., Regla-Nava J.A., Fernandez-Delgado R., Casta\u00f1o-Rodriguez C., Enjuanes L. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. PLoS Pathog. 2014;10:e1004320. doi: 10.1371/journal.ppat.1004320.", "ArticleIdList": ["10.1371/journal.ppat.1004320", "PMC4133396", "25122212"]}, {"Citation": "Shepley-McTaggart A., Sagum C.A., Oliva I., Rybakovsky E., DiGuilio K., Liang J., Bedford M.T., Cassel J., Sudol M., Mullin J.M., et al. SARS-CoV-2 envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein zo1. PLoS ONE. 2021;16:e0251955. doi: 10.1371/journal.pone.0251955.", "ArticleIdList": ["10.1371/journal.pone.0251955", "PMC8189464", "34106957"]}, {"Citation": "Arndt A.L., Larson B.J., Hogue B.G. A conserved domain in the coronavirus membrane protein tail is important for virus assembly. J. Virol. 2010;84:11418\u201311428. doi: 10.1128/JVI.01131-10.", "ArticleIdList": ["10.1128/JVI.01131-10", "PMC2953170", "20719948"]}, {"Citation": "Wang Q., Wong G., Lu G., Yan J., Gao G.F. MERS-COV spike protein: Targets for vaccines and therapeutics. Antivir. Res. 2016;133:165\u2013177. doi: 10.1016/j.antiviral.2016.07.015.", "ArticleIdList": ["10.1016/j.antiviral.2016.07.015", "PMC7113765", "27468951"]}, {"Citation": "Bianchi M., Benvenuto D., Giovanetti M., Angeletti S., Ciccozzi M., Pascarella S. SARS-CoV-2 envelope and membrane proteins: Structural differences linked to virus characteristics? BioMed Res. Int. 2020;2020:4389089. doi: 10.1155/2020/4389089.", "ArticleIdList": ["10.1155/2020/4389089", "PMC7261327", "32596311"]}, {"Citation": "Chang C.-K., Hou M.-H., Chang C.-F., Hsiao C.-D., Huang T.-H. The SARS coronavirus nucleocapsid protein\u2014Forms and functions. Antivir. Res. 2014;103:39\u201350. doi: 10.1016/j.antiviral.2013.12.009.", "ArticleIdList": ["10.1016/j.antiviral.2013.12.009", "PMC7113676", "24418573"]}, {"Citation": "Chang C.-K., Jeyachandran S., Hu N.-J., Liu C.-L., Lin S.-Y., Wang Y.-S., Chang Y.-M., Hou M.-H. Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein. Mol. BioSystems. 2016;12:59\u201366. doi: 10.1039/C5MB00582E.", "ArticleIdList": ["10.1039/C5MB00582E", "26542199"]}, {"Citation": "Lindner H.A., Fotouhi-Ardakani N., Lytvyn V., Lachance P., Sulea T., M\u00e9nard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 2005;79:15199\u201315208. doi: 10.1128/JVI.79.24.15199-15208.2005.", "ArticleIdList": ["10.1128/JVI.79.24.15199-15208.2005", "PMC1316033", "16306591"]}, {"Citation": "Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., Baker S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 2005;79:15189\u201315198. doi: 10.1128/JVI.79.24.15189-15198.2005.", "ArticleIdList": ["10.1128/JVI.79.24.15189-15198.2005", "PMC1316023", "16306590"]}, {"Citation": "Stadler K., Ha H.R., Ciminale V., Spirli C., Saletti G., Schiavon M., Bruttomesso D., Bigler L., Follath F., Pettenazzo A., et al. Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am. J. Respir. Cell Mol. Biol. 2008;39:142\u2013149. doi: 10.1165/rcmb.2007-0217OC.", "ArticleIdList": ["10.1165/rcmb.2007-0217OC", "18314540"]}, {"Citation": "Rosa R.B., Dantas W.M., do Nascimento J.C.F., da Silva M.V., de Oliveira R.N., Pena L.J. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic. Viruses. 2021;13:379. doi: 10.3390/v13030379.", "ArticleIdList": ["10.3390/v13030379", "PMC7997194", "33673614"]}, {"Citation": "Guijarro-Real C., Plazas M., Rodr\u00edguez-Burruezo A., Prohens J., Fita A. Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity. Foods. 2021;10:1503. doi: 10.3390/foods10071503.", "ArticleIdList": ["10.3390/foods10071503", "PMC8304378", "34209659"]}, {"Citation": "Yoo D.Y., Kim W., Nam S.M., Yoo M., Lee S., Yoon Y.S., Won M.-H., Hwang I.K., Choi J.H. Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia. Food Chem. Toxicol. 2014;72:1\u20137. doi: 10.1016/j.fct.2014.06.023.", "ArticleIdList": ["10.1016/j.fct.2014.06.023", "24997311"]}, {"Citation": "Ankri S., Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999;1:125\u2013129. doi: 10.1016/S1286-4579(99)80003-3.", "ArticleIdList": ["10.1016/S1286-4579(99)80003-3", "10594976"]}, {"Citation": "Singh P., Singh J., Singh S., Singh B.R. Medicinal values of garlic (Allium sativum L.) in human life: An overview. Greener J. Agric. Sci. 2014;4:265\u2013280. doi: 10.15580/GJAS.2014.6.031914151.", "ArticleIdList": ["10.15580/GJAS.2014.6.031914151"]}, {"Citation": "Mair C.E., Liu R., Atanasov A.G., Schmidtke M., Dirsch V.M., Rollinger J.M. Antiviral and anti-proliferative in vitro activities of piperamides from black pepper. Planta Med. 2016;82:S1\u2013S381. doi: 10.1055/s-0036-1596830.", "ArticleIdList": ["10.1055/s-0036-1596830"]}, {"Citation": "Barakat A.B., Shoman S.A., Dina N., Alfarouk O.R. Antiviral activity and mode of action of Dianthus caryophyllus L. and Lupinus termes L. seed extracts against in vitro herpes simplex and hepatitis A viruses infection. J. Microbiol. Antimicrob. 2010;2:23\u201329."}, {"Citation": "Mounce B.C., Cesaro T., Carrau L., Vallet T., Vignuzzi M. Curcumin inhibits zika and chikungunya virus infection by inhibiting cell binding. Antivir. Res. 2017;142:148\u2013157. doi: 10.1016/j.antiviral.2017.03.014.", "ArticleIdList": ["10.1016/j.antiviral.2017.03.014", "28343845"]}, {"Citation": "Chandra Manivannan A., Malaisamy A., Eswaran M., Meyyazhagan A., Arumugam V.A., Rengasamy K.R., Balasubramanian B., Liu W.-C. Evaluation of clove phytochemicals as potential antiviral drug candidates targeting SARS-CoV-2 main protease: Computational Docking, molecular dynamics simulation, and pharmacokinetic profiling. Front. Mol. Biosci. 2022;9:918101. doi: 10.3389/fmolb.2022.918101.", "ArticleIdList": ["10.3389/fmolb.2022.918101", "PMC9273859", "35836934"]}, {"Citation": "Wi\u0144ska K., M\u0105czka W., \u0141yczko J., Grabarczyk M., Czubaszek A., Szumny A. Essential oils as antimicrobial agents\u2014Myth or real alternative? Molecules. 2019;24:2130. doi: 10.3390/molecules24112130.", "ArticleIdList": ["10.3390/molecules24112130", "PMC6612361", "31195752"]}, {"Citation": "Orhan I.E., Senol Deniz F.S. Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS-CoV-2? Nat. Prod. Bioprospecting. 2020;10:171\u2013186. doi: 10.1007/s13659-020-00250-4.", "ArticleIdList": ["10.1007/s13659-020-00250-4", "PMC7289229", "32529545"]}, {"Citation": "Loizzo M.R., Saab A.M., Tundis R., Statti G.A., Menichini F., Lampronti I., Gambari R., Cinatl J., Doerr H.W. Phytochemical analysis andin vitro antiviral activities of the essential oils of seven Lebanon species. Chem. Biodivers. 2008;5:461\u2013470. doi: 10.1002/cbdv.200890045.", "ArticleIdList": ["10.1002/cbdv.200890045", "PMC7161995", "18357554"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. Potential Inhibitor of COVID-19 Main Protease (Mpro) from Several Medicinal Plant Compounds by Molecular Docking Study. Preprints. 2020:2020030226. doi: 10.20944/preprints202003.0226.v1.", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Ho T., Wu S., Chen J., Li C., Hsiang C. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir. Res. 2007;74:92\u2013101. doi: 10.1016/j.antiviral.2006.04.014.", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Aggarwal B.B., Van Kuiken M.E., Iyer L.H., Harikumar K.B., Sung B. Molecular targets of nutraceuticals derived from dietary spices: Potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med. 2009;234:825\u2013849. doi: 10.3181/0902-MR-78.", "ArticleIdList": ["10.3181/0902-MR-78", "PMC3141288", "19491364"]}, {"Citation": "Mansouri S., Choudhary G., Sarzala P.M., Ratner L., Hudak K.A. Suppression of human T-cell leukemia virus I gene expression by pokeweed antiviral protein. J. Biol. Chem. 2009;284:31453\u201331462. doi: 10.1074/jbc.M109.046235.", "ArticleIdList": ["10.1074/jbc.M109.046235", "PMC2781541", "19748897"]}, {"Citation": "Kaladhar D., Nandikolla S.K. Antimicrobial studies, Biochemical and image analysis in Mirabilis lalapa Linn. Int. J. Farm. Tech. 2010;2:683\u2013693."}, {"Citation": "Tran J. Green tea: A potential alternative anti-infectious agent catechins and viral infections. Adv. Anthropol. 2013;3:198\u2013202. doi: 10.4236/aa.2013.34028.", "ArticleIdList": ["10.4236/aa.2013.34028"]}, {"Citation": "Jin S. Therapeutic potential of natural catechins in antiviral activity. JSM Biotechnol. Biomed. Eng. 2013;1:1002."}, {"Citation": "Kim H.-Y., Eo E.-Y., Park H., Kim Y.-C., Park S., Shin H.-J., Kim K. Medicinal herbal extracts of sophorae radix ACANTHOPANACIS cortex sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro. Antivir. Ther. 2010;15:697\u2013709. doi: 10.3851/IMP1615.", "ArticleIdList": ["10.3851/IMP1615", "20710051"]}, {"Citation": "Kim H.-Y., Shin H.-S., Park H., Kim Y.-C., Yun Y.G., Park S., Shin H.-J., Kim K. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, CIMICIFUGA rhizoma, meliae cortex, coptidis rhizoma, and Phellodendron Cortex. J. Clin. Virol. 2008;41:122\u2013128. doi: 10.1016/j.jcv.2007.10.011.", "ArticleIdList": ["10.1016/j.jcv.2007.10.011", "PMC7108295", "18036887"]}, {"Citation": "Chang F.-R., Yen C.-T., EI-Shazly M., Lin W.-H., Yen M.-H., Lin K.-H., Wu Y.-C. Anti-human coronavirus (anti-hcov) triterpenoids from the leaves of Euphorbia neriifolia. Nat. Prod. Commun. 2012;7:1415\u20131417. doi: 10.1177/1934578X1200701103.", "ArticleIdList": ["10.1177/1934578X1200701103", "23285797"]}, {"Citation": "Chen C.-J., Michaelis M., Hsu H.-K., Tsai C.-C., Yang K.D., Wu Y.-C., Cinatl J., Doerr H.W. Toona sinensis roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 2008;120:108\u2013111. doi: 10.1016/j.jep.2008.07.048.", "ArticleIdList": ["10.1016/j.jep.2008.07.048", "PMC7127248", "18762235"]}, {"Citation": "Cho J.K., Curtis-Long M.J., Lee K.H., Kim D.W., Ryu H.W., Yuk H.J., Park K.H. Geranylated flavonoids displaying SARS-COV papain-like protease inhibition from the fruits of paulownia tomentosa. Bioorganic Med. Chem. 2013;21:3051\u20133057. doi: 10.1016/j.bmc.2013.03.027.", "ArticleIdList": ["10.1016/j.bmc.2013.03.027", "PMC7126831", "23623680"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., Bielenberg J. Antiviral effects ofglycyrrhiza species. Phytother. Res. 2008;22:141\u2013148. doi: 10.1002/ptr.2295.", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Asl M.N., Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother. Res. 2008;22:709\u2013724. doi: 10.1002/ptr.2362.", "ArticleIdList": ["10.1002/ptr.2362", "PMC7167813", "18446848"]}, {"Citation": "Das S.K., Das V., Gulati A.K., Singh V.P. Deglycyrrhizinated liquorice in aphthous ulcers. J. Assoc. Phys. India. 1989;37:647.", "ArticleIdList": ["2632514"]}, {"Citation": "Krausse R. In vitro anti-helicobacter pylori activity of extractum liquiritiae, glycyrrhizin and its metabolites. J. Antimicrob. Chemother. 2004;54:243\u2013246. doi: 10.1093/jac/dkh287.", "ArticleIdList": ["10.1093/jac/dkh287", "15190039"]}, {"Citation": "Chen F., Chan K.H., Jiang Y., Kao R.Y.T., Lu H.T., Fan K.W., Cheng V.C.C., Tsui W.H.W., Hung I.F.N., Lee T.S.W. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 2004;31:69\u201375. doi: 10.1016/j.jcv.2004.03.003.", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046. doi: 10.1016/S0140-6736(03)13615-X.", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Massi A., Bortolini O., Ragno D., Bernardi T., Sacchetti G., Tacchini M., De Risi C. Research progress in the modification of quercetin leading to anticancer agents. Molecules. 2017;22:1270. doi: 10.3390/molecules22081270.", "ArticleIdList": ["10.3390/molecules22081270", "PMC6152094", "28758919"]}, {"Citation": "Chen L., Li J., Luo C., Liu H., Xu W., Chen G., Liew O.W., Zhu W., Puah C.M., Shen X., et al. Binding interaction of quercetin-3-\u03b2-galactoside and its synthetic derivatives with SARS-CoV 3clpro: Structure\u2013activity relationship studies reveal salient pharmacophore features. Bioorganic Med. Chem. 2006;14:8295\u20138306. doi: 10.1016/j.bmc.2006.09.014.", "ArticleIdList": ["10.1016/j.bmc.2006.09.014", "PMC7125754", "17046271"]}, {"Citation": "Wen C.-C., Shyur L.-F., Jan J.-T., Liang P.-H., Kuo C.-J., Arulselvan P., Wu J.-B., Kuo S.-C., Yang N.-S. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-COV replication. J. Tradit. Complement. Med. 2011;1:41\u201350. doi: 10.1016/S2225-4110(16)30055-4.", "ArticleIdList": ["10.1016/S2225-4110(16)30055-4", "PMC3942999", "24716104"]}, {"Citation": "Brendler T., Al-Harrasi A., Bauer R., Gafner S., Hardy M.L., Heinrich M., Hosseinzadeh H., Izzo A.A., Michaelis M., Nassiri-Asl M., et al. Botanical Drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice. Phytother. Res. 2020;35:3013\u20133031. doi: 10.1002/ptr.7008.", "ArticleIdList": ["10.1002/ptr.7008", "33373071"]}, {"Citation": "Cheng P.-W., Ng L.-T., Chiang L.-C., Lin C.-C. Antiviral effects of SAIKOSAPONINS on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33:612\u2013616. doi: 10.1111/j.1440-1681.2006.04415.x.", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}, {"Citation": "Yang F., Dong X., Yin X., Wang W., You L., Ni J. Radix bupleuri: A review of traditional uses, botany, phytochemistry, pharmacology, and toxicology. BioMed Res. Int. 2017;2017:7597596. doi: 10.1155/2017/7597596.", "ArticleIdList": ["10.1155/2017/7597596", "PMC5448051", "28593176"]}, {"Citation": "El-Saber Batiha G., Beshbishy A.M., El-Mleeh A., Abdel-Daim M.M., Devkota H.P. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (fabaceae) Biomolecules. 2020;10:352. doi: 10.3390/biom10030352.", "ArticleIdList": ["10.3390/biom10030352", "PMC7175350", "32106571"]}, {"Citation": "Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. Int. J. Biol. Sci. 2020;16:1708\u20131717. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Liu H., Ye F., Sun Q., Liang H., Li C., Li S., Lu R., Huang B., Tan W., Lai L. Scutellaria baicalensis extract and Baicalein inhibit replication of SARS-COV-2 and its 3c-like protease in vitro. J. Enzym. Inhib. Med. Chem. 2021;36:497\u2013503. doi: 10.1080/14756366.2021.1873977.", "ArticleIdList": ["10.1080/14756366.2021.1873977", "PMC7850424", "33491508"]}, {"Citation": "Lau K.-M., Lee K.-M., Koon C.-M., Cheung C.S.-F., Lau C.-P., Ho H.-M., Lee M.Y.-H., Au S.W.-N., Cheng C.H.-K., Lau C.B.-S., et al. Immunomodulatory and anti-SARS activities of Houttuynia Cordata. J. Ethnopharmacol. 2008;118:79\u201385. doi: 10.1016/j.jep.2008.03.018.", "ArticleIdList": ["10.1016/j.jep.2008.03.018", "PMC7126383", "18479853"]}, {"Citation": "Dang S.-S., Jia X.-L., Song P., Cheng Y.-A., Zhang X., Sun M.-Z., Liu E.-Q. Inhibitory effect of emodin and astragalus polysaccharideon the replication of HBV. World J. Gastroenterol. 2009;15:5669. doi: 10.3748/wjg.15.5669.", "ArticleIdList": ["10.3748/wjg.15.5669", "PMC2789219", "19960563"]}, {"Citation": "Sethu S., Shetty R., Ghosh A., Honavar S.G., Khamar P. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future. Indian J. Ophthalmol. 2020;68:693. doi: 10.4103/ijo.IJO_639_20.", "ArticleIdList": ["10.4103/ijo.IJO_639_20", "PMC7350468", "32317431"]}, {"Citation": "Park J.-Y., Jae Jeong H., Hoon Kim J., Min Kim Y., Park S.-J., Kim D., Hun Park K., Song Lee W., Bae Ryu Y. Diarylheptanoids from alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol. Pharm. Bull. 2012;35:2036\u20132042. doi: 10.1248/bpb.b12-00623.", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Capell T., Twyman R.M., Armario-Najera V., Ma J.K.-C., Schillberg S., Christou P. Potential applications of plant biotechnology against SARS-CoV-2. Trends Plant Sci. 2020;25:635\u2013643. doi: 10.1016/j.tplants.2020.04.009.", "ArticleIdList": ["10.1016/j.tplants.2020.04.009", "PMC7181989", "32371057"]}, {"Citation": "Heinrich M., Appendino G., Efferth T., F\u00fcrst R., Izzo A.A., Kayser O., Pezzuto J.M., Viljoen A. Best practice in research\u2014Overcoming common challenges in phytopharmacological research. J. Ethnopharmacol. 2020;246:112230. doi: 10.1016/j.jep.2019.112230.", "ArticleIdList": ["10.1016/j.jep.2019.112230", "31526860"]}, {"Citation": "Patten G.S., Abeywardena M.Y., Bennett L.E. Inhibition of angiotensin converting enzyme, angiotensin II receptor blocking, and blood pressure lowering bioactivity across plant families. Crit. Rev. Food Sci. Nutr. 2013;56:181\u2013214. doi: 10.1080/10408398.2011.651176.", "ArticleIdList": ["10.1080/10408398.2011.651176", "24915402"]}, {"Citation": "Takahashi S., Yoshiya T., Yoshizawa-Kumagaye K., Sugiyama T. Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed. Res. 2015;36:219\u2013224. doi: 10.2220/biomedres.36.219.", "ArticleIdList": ["10.2220/biomedres.36.219", "26106051"]}, {"Citation": "Siddesha J.M., D\u2019Souza C., Vishwanath B.S. Recent Progress in Medicinal Plants. Volume 29 Studium Press LLC; New Delhi, India: 2010. Inhibition of angiotensin converting enzyme (ACE) by medicinal plants exhibiting antihypertensive activity."}, {"Citation": "Liu J.-C., Hsu F.-L., Tsai J.-C., Chan P., Liu J.Y.-H., Thomas G.N., Tomlinson B., Lo M.-Y., Lin J.-Y. Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme. Life Sci. 2003;73:1543\u20131555. doi: 10.1016/S0024-3205(03)00481-8.", "ArticleIdList": ["10.1016/S0024-3205(03)00481-8", "12865094"]}, {"Citation": "Loizzo M.R., Saab A.M., Tundis R., Menichini F., Bonesi M., Piccolo V., Statti G.A., de Cindio B., Houghton P.J., Menichini F. In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. J. Ethnopharmacol. 2008;119:109\u2013116. doi: 10.1016/j.jep.2008.06.003.", "ArticleIdList": ["10.1016/j.jep.2008.06.003", "18601990"]}, {"Citation": "Charoonratana T., Madaka F. Angiotensin-converting enzyme inhibitory activity of Senna garrettiana active compounds: Potential markers for standardized herbal medicines. Pharmacogn. Mag. 2018;14:335. doi: 10.4103/pm.pm_325_17.", "ArticleIdList": ["10.4103/pm.pm_325_17"]}, {"Citation": "Zhou Y., Hou Y., Shen J., Huang Y., Martin W., Cheng F. Network-based drug repurposing for Novel Coronavirus 2019-ncov/SARS-CoV-2. Cell Discov. 2020;6:14. doi: 10.1038/s41421-020-0153-3.", "ArticleIdList": ["10.1038/s41421-020-0153-3", "PMC7073332", "32194980"]}, {"Citation": "Weng J.-R., Lin C.-S., Lai H.-C., Lin Y.-P., Wang C.-Y., Tsai Y.-C., Wu K.-C., Huang S.-H., Lin C.-W. Antiviral activity of Sambucus formosananakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 2019;273:197767. doi: 10.1016/j.virusres.2019.197767.", "ArticleIdList": ["10.1016/j.virusres.2019.197767", "PMC7114872", "31560964"]}, {"Citation": "Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA. 2005;102:11876\u201311881. doi: 10.1073/pnas.0505577102.", "ArticleIdList": ["10.1073/pnas.0505577102", "PMC1188015", "16081529"]}, {"Citation": "Huang I.-C., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., Vasilieva N., Dermody T.S., Harrison S.C., Dormitzer P.R., et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ace2-expressing cells. J. Biol. Chem. 2006;281:3198\u20133203. doi: 10.1074/jbc.M508381200.", "ArticleIdList": ["10.1074/jbc.M508381200", "PMC8010168", "16339146"]}, {"Citation": "Wang S.-Q., Du Q.-S., Zhao K., Li A.-X., Wei D.-Q., Chou K.-C. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids. 2007;33:129\u2013135. doi: 10.1007/s00726-006-0403-1.", "ArticleIdList": ["10.1007/s00726-006-0403-1", "PMC7087620", "16998715"]}, {"Citation": "Mouffouk C., Mouffouk S., Mouffouk S., Hambaba L., Haba H. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), Spike protein, RNA-dependent RNA polymerase (rdrp) and angiotensin-converting enzyme II receptor (ACE2) Eur. J. Pharmacol. 2021;891:173759. doi: 10.1016/j.ejphar.2020.173759.", "ArticleIdList": ["10.1016/j.ejphar.2020.173759", "PMC7691142", "33249077"]}, {"Citation": "Naidu S.A., Mustafa G., Clemens R.A., Naidu A.S. Plant-derived natural non-nucleoside analog inhibitors (nnais) against RNA-dependent RNA polymerase complex (NSP7/NSP8/NSP12) of SARS-CoV-2. J. Diet. Suppl. 2021:1\u201330. doi: 10.1080/19390211.2021.2006387.", "ArticleIdList": ["10.1080/19390211.2021.2006387", "34850656"]}, {"Citation": "Bai X., Sun H., Wu S., Li Y., Wang L., Hong B. Identifying small-molecule inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase by establishing a fluorometric assay. Front. Immunol. 2022;13:844749. doi: 10.3389/fimmu.2022.844749.", "ArticleIdList": ["10.3389/fimmu.2022.844749", "PMC9021610", "35464436"]}, {"Citation": "Shannon A., Le N.T.-T., Selisko B., Eydoux C., Alvarez K., Guillemot J.-C., Decroly E., Peersen O., Ferron F., Canard B. Remdesivir and SARS-CoV-2: Structural requirements at both NSP12 RDRP and NSP14 exonuclease active-sites. Antivir. Res. 2020;178:104793. doi: 10.1016/j.antiviral.2020.104793.", "ArticleIdList": ["10.1016/j.antiviral.2020.104793", "PMC7151495", "32283108"]}, {"Citation": "Bibi S., Khan M.S., El-Kafrawy S.A., Alandijany T.A., El-Daly M.M., Yousafi Q., Fatima D., Faizo A.A., Bajrai L.H., Azhar E.I. Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3clpro. Saudi Pharm. J. 2022;30:979\u20131002. doi: 10.1016/j.jsps.2022.05.003.", "ArticleIdList": ["10.1016/j.jsps.2022.05.003", "PMC9132386", "35637849"]}, {"Citation": "Moustaqil M., Ollivier E., Chiu H.-P., Van Tol S., Rudolffi-Soto P., Stevens C., Bhumkar A., Hunter D.J., Freiberg A.N., Jacques D., et al. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): Implications for disease presentation across species. Emerg. Microbes Infect. 2021;10:178\u2013195. doi: 10.1080/22221751.2020.1870414.", "ArticleIdList": ["10.1080/22221751.2020.1870414", "PMC7850364", "33372854"]}, {"Citation": "Fung S.-Y., Siu K.-L., Lin H., Yeung M.L., Jin D.-Y. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3. Int. J. Biol. Sci. 2021;17:1547\u20131554. doi: 10.7150/ijbs.59943.", "ArticleIdList": ["10.7150/ijbs.59943", "PMC8071772", "33907518"]}, {"Citation": "Derosa G., Maffioli P., D\u2019Angelo A., Di Pierro F. A role for quercetin in coronavirus disease 2019 (COVID-19) Phytother. Res. 2020;35:1230\u20131236. doi: 10.1002/ptr.6887.", "ArticleIdList": ["10.1002/ptr.6887", "PMC7675685", "33034398"]}, {"Citation": "Shen Z., Ratia K., Cooper L., Kong D., Lee H., Kwon Y., Li Y., Alqarni S., Huang F., Dubrovskyi O., et al. Potent, novel SARS-CoV-2 plpro inhibitors block viral replication in monkey and human cell cultures. J. Med. Chem. 2021;65:2940\u20132955. doi: 10.1021/acs.jmedchem.1c01307.", "ArticleIdList": ["10.1021/acs.jmedchem.1c01307", "PMC8547495", "34665619"]}, {"Citation": "Singh S., Sk M.F., Sonawane A., Kar P., Sadhukhan S. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via rna-dependent RNA polymerase (rdrp) inhibition: An in-silico analysis. J. Biomol. Struct. Dyn. 2021;39:6249\u20136264. doi: 10.1080/07391102.2020.1796810.", "ArticleIdList": ["10.1080/07391102.2020.1796810", "PMC7441777", "32720577"]}, {"Citation": "Swargiary A., Mahmud S., Saleh M.A. Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: An in silico approach to combat COVID-19. J. Biomol. Struct. Dyn. 2020;40:2067\u20132081. doi: 10.1080/07391102.2020.1835729.", "ArticleIdList": ["10.1080/07391102.2020.1835729", "PMC7594184", "33089730"]}, {"Citation": "Zrieq R., Ahmad I., Snoussi M., Noumi E., Iriti M., Algahtani F.D., Patel H., Saeed M., Tasleem M., Sulaiman S., et al. Tomatidine and patchouli alcohol as inhibitors of SARS-CoV-2 enzymes (3CLpro, PLpro and NSP15) by molecular docking and molecular dynamics simulations. Int. J. Mol. Sci. 2021;22:10693. doi: 10.3390/ijms221910693.", "ArticleIdList": ["10.3390/ijms221910693", "PMC8509278", "34639036"]}, {"Citation": "Gupta Y., Maciorowski D., Zak S.E., Jones K.A., Kathayat R.S., Azizi S.-A., Mathur R., Pearce C.M., Ilc D.J., Husein H., et al. Bisindolylmaleimide IX: A novel anti-SARS-cov2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 2021;195:57\u201371. doi: 10.1016/j.ymeth.2021.01.003.", "ArticleIdList": ["10.1016/j.ymeth.2021.01.003", "PMC7807167", "33453392"]}, {"Citation": "Lewis D.S., Ho J., Wills S., Kawall A., Sharma A., Chavada K., Ebert M.C., Evoli S., Singh A., Rayalam S., et al. Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro. Sci. Rep. 2022;12:2145. doi: 10.1038/s41598-022-06104-y.", "ArticleIdList": ["10.1038/s41598-022-06104-y", "PMC8828865", "35140265"]}, {"Citation": "Zhang D.-H., Wu K.-L., Zhang X., Deng S.-Q., Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 2020;18:152\u2013158. doi: 10.1016/j.joim.2020.02.005.", "ArticleIdList": ["10.1016/j.joim.2020.02.005", "PMC7102521", "32113846"]}, {"Citation": "Shawan M.M., Halder S.K., Hasan M.A. Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: An in silico molecular modeling approach in battling the COVID-19 outbreak. Bull. Natl. Res. Cent. 2021;45:27. doi: 10.1186/s42269-020-00479-6.", "ArticleIdList": ["10.1186/s42269-020-00479-6", "PMC7816153", "33495684"]}, {"Citation": "Shree P., Mishra P., Selvaraj C., Singh S.K., Chaube R., Garg N., Tripathi Y.B. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants\u2014Withania somnifera (ashwagandha), Tinospora cordifolia (giloy) and Ocimum sanctum (tulsi)\u2014A molecular docking study. J. Biomol. Struct. Dyn. 2020;40:190\u2013203. doi: 10.1080/07391102.2020.1810778.", "ArticleIdList": ["10.1080/07391102.2020.1810778", "PMC7484581", "32851919"]}, {"Citation": "Gyebi G.A., Ogunyemi O.M., Ibrahim I.M., Afolabi S.O., Adebayo J.O. Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective. Comput. Biol. Med. 2021;134:104406. doi: 10.1016/j.compbiomed.2021.104406.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104406", "PMC8053224", "33915479"]}, {"Citation": "Balkrishna A., Pokhrel S., Singh J., Varshney A. Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. Drug Des. Dev. Ther. 2020;15:1111\u20131133. doi: 10.2147/DDDT.S292805.", "ArticleIdList": ["10.2147/DDDT.S292805", "PMC7961299", "33737804"]}, {"Citation": "Paul D., Sanap G., Shenoy S., Kalyane D., Kalia K., Tekade R.K. Artificial Intelligence in drug discovery and development. Drug Discov. Today. 2021;26:80\u201393. doi: 10.1016/j.drudis.2020.10.010.", "ArticleIdList": ["10.1016/j.drudis.2020.10.010", "PMC7577280", "33099022"]}, {"Citation": "Floresta G., Zagni C., Gentile D., Patamia V., Rescifina A. Artificial Intelligence Technologies for COVID-19 de Novo Drug Design. Int. J. Mol. Sci. 2022;23:3261. doi: 10.3390/ijms23063261.", "ArticleIdList": ["10.3390/ijms23063261", "PMC8949797", "35328682"]}, {"Citation": "Vasighi M., Romanova J., Nedyalkova M. A multilevel approach for screening natural compounds as an antiviral agent for COVID-19. Comput. Biol. Chem. 2022;98:107694. doi: 10.1016/j.compbiolchem.2022.107694.", "ArticleIdList": ["10.1016/j.compbiolchem.2022.107694", "PMC9090871", "35576744"]}, {"Citation": "Kim C.-H. Anti\u2013SARS-CoV-2 natural products as potentially therapeutic agents. Front. Pharmacol. 2021;12:590509. doi: 10.3389/fphar.2021.590509.", "ArticleIdList": ["10.3389/fphar.2021.590509", "PMC8194829", "34122058"]}, {"Citation": "Abubaker Bagabir S., Ibrahim N.K., Abubaker Bagabir H., Hashem Ateeq R. COVID-19 and Artificial Intelligence: Genome sequencing, drug development and Vaccine Discovery. J. Infect. Public Health. 2022;15:289\u2013296. doi: 10.1016/j.jiph.2022.01.011.", "ArticleIdList": ["10.1016/j.jiph.2022.01.011", "PMC8767913", "35078755"]}, {"Citation": "Govianda B.K.C., Bocci G., Verma S., Hassan M.M., Holmes J., Yang J.J., Sirimulla S., Oprea T.I. A machine learning platform to estimate anti-SARS-CoV-2 activities. Nat. Mach. Intell. 2021;3:527\u2013535."}, {"Citation": "Keshavarzi Arshadi A., Webb J., Salem M., Cruz E., Calad-Thomson S., Ghadirian N., Collins J., Diez-Cecilia E., Kelly B., Goodarzi H., et al. Artificial Intelligence for COVID-19 drug discovery and vaccine development. Front. Artif. Intell. 2020;3:65. doi: 10.3389/frai.2020.00065.", "ArticleIdList": ["10.3389/frai.2020.00065", "PMC7861281", "33733182"]}, {"Citation": "Dhama K., Natesan S., Iqbal Yatoo M., Patel S.K., Tiwari R., Saxena S.K., Harapan H. Plant-based vaccines and antibodies to combat COVID-19: Current status and prospects. Hum. Vaccines Immunother. 2020;16:2913\u20132920. doi: 10.1080/21645515.2020.1842034.", "ArticleIdList": ["10.1080/21645515.2020.1842034", "PMC7754927", "33270484"]}, {"Citation": "Kurup V.M., Thomas J. Edible vaccines: Promises and challenges. Mol. Biotechnol. 2019;62:79\u201390. doi: 10.1007/s12033-019-00222-1.", "ArticleIdList": ["10.1007/s12033-019-00222-1", "PMC7090473", "31758488"]}, {"Citation": "Turner R.B., Felton A., Kosak K., Kelsey D.K., Meschievitz C.K. Prevention of experimental coronavirus colds with intranasal -2b interferon. J. Infect. Dis. 1986;154:443\u2013447. doi: 10.1093/infdis/154.3.443.", "ArticleIdList": ["10.1093/infdis/154.3.443", "PMC7110151", "3016111"]}, {"Citation": "Mustafa S., Balkhy H., Gabere M.N. Current treatment options and the role of peptides as potential therapeutic components for Middle East respiratory syndrome (MERS): A Review. J. Infect. Public Health. 2018;11:9\u201317. doi: 10.1016/j.jiph.2017.08.009.", "ArticleIdList": ["10.1016/j.jiph.2017.08.009", "PMC7102797", "28864360"]}, {"Citation": "Lew T.W. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:374. doi: 10.1001/jama.290.3.374.", "ArticleIdList": ["10.1001/jama.290.3.374", "12865379"]}, {"Citation": "Costantini C., Bellet M.M., Pariano M., Renga G., Stincardini C., Goldstein A.L., Garaci E., Romani L. A reappraisal of Thymosin Alpha1 in cancer therapy. Front. Oncol. 2019;9:873. doi: 10.3389/fonc.2019.00873.", "ArticleIdList": ["10.3389/fonc.2019.00873", "PMC6742685", "31555601"]}, {"Citation": "Z\u00e1ruba K., Rastorfer M., Grob P.J., Joller-Jemelka H., Bolla K. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination. Lancet. 1983;322:1245. doi: 10.1016/S0140-6736(83)91284-9.", "ArticleIdList": ["10.1016/S0140-6736(83)91284-9", "6139582"]}, {"Citation": "Wei L. Study on Expression of Thymosin \u03b11 with Plant Bioreactor. J. Sichuan Norm. Univ. 2009;1:112\u2013117."}, {"Citation": "Cui L., Chen Y., Shen G., Zhao L., Tang K. Expression of bioactive thymosin alpha 1 (TA1) in marker-free transgenic lettuce (Lactuca sativa) Plant Mol. Biol. Report. 2010;29:466\u2013472. doi: 10.1007/s11105-010-0246-5.", "ArticleIdList": ["10.1007/s11105-010-0246-5"]}, {"Citation": "Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human MAB to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA. 2004;101:2536\u20132541. doi: 10.1073/pnas.0307140101.", "ArticleIdList": ["10.1073/pnas.0307140101", "PMC356985", "14983044"]}, {"Citation": "Moussavou G., Ko K., Lee J.-H., Choo Y.-K. Production of monoclonal antibodies in plants for cancer immunotherapy. BioMed Res. Int. 2015;2015:306164. doi: 10.1155/2015/306164.", "ArticleIdList": ["10.1155/2015/306164", "PMC4624878", "26550566"]}, {"Citation": "Boechat J.L., Chora I., Morais A., Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology\u2014Current perspectives. Pulmonology. 2021;27:423\u2013437. doi: 10.1016/j.pulmoe.2021.03.008.", "ArticleIdList": ["10.1016/j.pulmoe.2021.03.008", "PMC8040543", "33867315"]}, {"Citation": "Alqazlan N., Diao H., Jevnikar A.M., Ma S. Production of functional human interleukin 37 using plants. Plant Cell Rep. 2019;38:391\u2013401. doi: 10.1007/s00299-019-02377-2.", "ArticleIdList": ["10.1007/s00299-019-02377-2", "30659328"]}, {"Citation": "Michot J.-M., Albiges L., Chaput N., Saada V., Pommeret F., Griscelli F., Balleyguier C., Besse B., Marabelle A., Netzer F., et al. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: A case report. Ann. Oncol. 2020;31:961\u2013964. doi: 10.1016/j.annonc.2020.03.300.", "ArticleIdList": ["10.1016/j.annonc.2020.03.300", "PMC7136869", "32247642"]}, {"Citation": "Wampler Muskardin T.L. Intravenous anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of coronavirus disease 2019. ACR Open Rheumatol. 2020;2:283\u2013285. doi: 10.1002/acr2.11140.", "ArticleIdList": ["10.1002/acr2.11140", "PMC7231517", "32267072"]}, {"Citation": "Cai C., Koch B., Morikawa K., Suda G., Sakamoto N., Rueschenbaum S., Akhras S., Dietz J., Hildt E., Zeuzem S., et al. Macrophage-derived extracellular vesicles induce long-lasting immunity against hepatitis C virus which is blunted by polyunsaturated fatty acids. Front. Immunol. 2018;9:723. doi: 10.3389/fimmu.2018.00723.", "ArticleIdList": ["10.3389/fimmu.2018.00723", "PMC5906748", "29706960"]}, {"Citation": "Favalli E.G., Ingegnoli F., De Lucia O., Cincinelli G., Cimaz R., Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun. Rev. 2020;19:102523. doi: 10.1016/j.autrev.2020.102523.", "ArticleIdList": ["10.1016/j.autrev.2020.102523", "PMC7102591", "32205186"]}, {"Citation": "Atherton J.G., Kratzing C.C., Fisher A. The effect of ascorbic acid on infection of chick-embryo ciliated tracheal organ cultures by coronavirus. Arch. Virol. 1978;56:195\u2013199. doi: 10.1007/BF01317848.", "ArticleIdList": ["10.1007/BF01317848", "PMC7087159", "205194"]}, {"Citation": "Joffe M.I., Sukha N.R., Rabson A.R. Lymphocyte subsets in measles. depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid. J. Clin. Investig. 1983;72:971\u2013980. doi: 10.1172/JCI111069.", "ArticleIdList": ["10.1172/JCI111069", "PMC1129263", "6604071"]}, {"Citation": "Pfefferle S., Sch\u00f6pf J., K\u00f6gl M., Friedel C.C., M\u00fcller M.A., Carbajo-Lozoya J., Stellberger T., von Dall\u2019Armi E., Herzog P., Kallies S., et al. The sars-coronavirus-host interactome: Identification of cyclophilins as target for Pan-Coronavirus inhibitors. PLoS Pathog. 2011;7:e1002331. doi: 10.1371/journal.ppat.1002331.", "ArticleIdList": ["10.1371/journal.ppat.1002331", "PMC3203193", "22046132"]}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro. Cell Res. 2020;30:269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Colson P., Rolain J.-M., Lagier J.-C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int. J. Antimicrob. Agents. 2020;55:105932. doi: 10.1016/j.ijantimicag.2020.105932.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105932", "PMC7135139", "32145363"]}, {"Citation": "Madrid P.B., Panchal R.G., Warren T.K., Shurtleff A.C., Endsley A.N., Green C.E., Kolokoltsov A., Davey R., Manger I.D., Gilfillan L., et al. Evaluation of ebola virus inhibitors for drug repurposing. ACS Infect. Dis. 2015;1:317\u2013326. doi: 10.1021/acsinfecdis.5b00030.", "ArticleIdList": ["10.1021/acsinfecdis.5b00030", "27622822"]}, {"Citation": "Bosseboeuf E., Aubry M., Nhan T., de Pina J.J., Rolain J.M., Raoult D., Musso D. Azithromycin inhibits the replication of zika virus. J. Antivir. Antiretrovir. 2018;10:6\u201311. doi: 10.4172/1948-5964.1000173.", "ArticleIdList": ["10.4172/1948-5964.1000173"]}, {"Citation": "Chen L., Lv D., Wang S., Wang D., Chen X., Liu Y., Hong Z., Zhu Z., Cao Y., Chai Y. Surface plasmon resonance-based membrane protein-targeted active ingredients recognition strategy: Construction and implementation in ligand screening from herbal medicines. Anal. Chem. 2020;92:3972\u20133980. doi: 10.1021/acs.analchem.9b05479.", "ArticleIdList": ["10.1021/acs.analchem.9b05479", "32045214"]}, {"Citation": "Wang C., Wang Z., Wang G., Lau J.Y.-N., Zhang K., Li W. COVID-19 in early 2021: Current status and looking forward. Signal Transduct. Target. Ther. 2021;6:114. doi: 10.1038/s41392-021-00527-1.", "ArticleIdList": ["10.1038/s41392-021-00527-1", "PMC7938042", "33686059"]}, {"Citation": "Leneva I., Kartashova N., Poromov A., Gracheva A., Korchevaya E., Glubokova E., Borisova O., Shtro A., Loginova S., Shchukina V., et al. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus. Viruses. 2021;13:1665. doi: 10.3390/v13081665.", "ArticleIdList": ["10.3390/v13081665", "PMC8402645", "34452529"]}, {"Citation": "Zhang Q., Wang Y., Qi C., Shen L., Li J. Clinical trial analysis of 2019-ncov therapy registered in China. J. Med. Virol. 2020;92:540\u2013545. doi: 10.1002/jmv.25733.", "ArticleIdList": ["10.1002/jmv.25733", "PMC7228274", "32108352"]}, {"Citation": "Ader F., Peiffer-Smadja N., Poissy J., Bouscambert-Duchamp M., Belhadi D., Diallo A., Delmas C., Saillard J., Dechanet A., Mercier N., et al. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\u03b2-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin. Microbiol. Infect. 2021;27:1826\u20131837. doi: 10.1016/j.cmi.2021.05.020.", "ArticleIdList": ["10.1016/j.cmi.2021.05.020", "PMC8149166", "34048876"]}, {"Citation": "Moscatelli F., Sessa F., Valenzano A., Polito R., Monda V., Cibelli G., Villano I., Pisanelli D., Perrella M., Daniele A., et al. COVID-19: Role of nutrition and supplementation. Nutrients. 2021;13:976. doi: 10.3390/nu13030976.", "ArticleIdList": ["10.3390/nu13030976", "PMC8002713", "33803015"]}, {"Citation": "Shakoor H., Feehan J., Al Dhaheri A.S., Ali H.I., Platat C., Ismail L.C., Apostolopoulos V., Stojanovska L. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021;143:1\u20139. doi: 10.1016/j.maturitas.2020.08.003.", "ArticleIdList": ["10.1016/j.maturitas.2020.08.003", "PMC7415215", "33308613"]}, {"Citation": "Berger M.M., Herter-Aeberli I., Zimmermann M.B., Spieldenner J., Eggersdorfer M. Strengthening the immunity of the Swiss population with micronutrients: A narrative review and call for action. Clin. Nutr. ESPEN. 2021;43:39\u201348. doi: 10.1016/j.clnesp.2021.03.012.", "ArticleIdList": ["10.1016/j.clnesp.2021.03.012", "PMC7987506", "34024545"]}, {"Citation": "Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J. Infect. Public Health. 2020;13:1373\u20131380. doi: 10.1016/j.jiph.2020.06.021.", "ArticleIdList": ["10.1016/j.jiph.2020.06.021", "PMC7305922", "32605780"]}, {"Citation": "Nonnecke B.J., McGill J.L., Ridpath J.F., Sacco R.E., Lippolis J.D., Reinhardt T.A. Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves. J. Dairy Sci. 2014;97:5566\u20135579. doi: 10.3168/jds.2014-8293.", "ArticleIdList": ["10.3168/jds.2014-8293", "25022687"]}, {"Citation": "West C.E., Sijtsma S.R., Kouwenhoven B., Rombout J.H.W.M., van der Zijpp A.J. Epithelia-damaging virus infections affect vitamin A status in chickens. J. Nutr. 1992;122:333\u2013339. doi: 10.1093/jn/122.2.333.", "ArticleIdList": ["10.1093/jn/122.2.333", "1310111"]}, {"Citation": "Kumar P., Kumar M., Bedi O., Gupta M., Kumar S., Jaiswal G., Rahi V., Yedke N.G., Bijalwan A., Sharma S., et al. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology. 2021;29:1001\u20131016. doi: 10.1007/s10787-021-00826-7.", "ArticleIdList": ["10.1007/s10787-021-00826-7", "PMC8190991", "34110533"]}, {"Citation": "Alexander J., Tinkov A., Strand T.A., Alehagen U., Skalny A., Aaseth J. Early nutritional interventions with zinc, selenium and vitamin D for raising anti-viral resistance against Progressive COVID-19. Nutrients. 2020;12:2358. doi: 10.3390/nu12082358.", "ArticleIdList": ["10.3390/nu12082358", "PMC7468884", "32784601"]}, {"Citation": "Te Velthuis A.J., van den Worm S.H., Sims A.C., Baric R.S., Snijder E.J., van Hemert M.J. Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6:e1001176. doi: 10.1371/journal.ppat.1001176.", "ArticleIdList": ["10.1371/journal.ppat.1001176", "PMC2973827", "21079686"]}, {"Citation": "Beck M.A., Shi Q., Morris V.C., Levander O.A. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1995;1:433\u2013436. doi: 10.1038/nm0595-433.", "ArticleIdList": ["10.1038/nm0595-433", "7585090"]}, {"Citation": "Nur S.M., Rath S., Ahmad V., Ahmad A., Ateeq B., Khan M.I. Nutritive vitamins as epidrugs. Crit. Rev. Food Sci. Nutr. 2020;61:1\u201313. doi: 10.1080/10408398.2020.1712674.", "ArticleIdList": ["10.1080/10408398.2020.1712674", "32023132"]}, {"Citation": "Habib H.M., Ibrahim S., Zaim A., Ibrahim W.H. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed. Pharmacother. 2021;136:111228. doi: 10.1016/j.biopha.2021.111228.", "ArticleIdList": ["10.1016/j.biopha.2021.111228", "PMC7836924", "33454595"]}, {"Citation": "Alam S., Bhuiyan F.R., Emon T.H., Hasan M. Prospects of nutritional interventions in the care of COVID-19 patients. Heliyon. 2021;7:e06285. doi: 10.1016/j.heliyon.2021.e06285.", "ArticleIdList": ["10.1016/j.heliyon.2021.e06285", "PMC7879162", "33615017"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "28"}, {"Year": "2022", "Month": "10", "Day": "6"}, {"Year": "2022", "Month": "11", "Day": "2"}, {"Year": "2022", "Month": "11", "Day": "11", "Hour": "1", "Minute": "29"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["36362351", "PMC9655040", "10.3390/ijms232113564", "ijms232113564"]}}], "PubmedBookArticle": []}